Progression-free survival (PFS) and overall survival (OS) in HER2-ve advanced breast cancer (ABC) patients (pts) according to the molecular subtype in the era of modern agents: Results from the GIM-13 AMBRA study.
Marina Elena Cazzaniga(Azienda Ospedaliera San Gerardo), Francesco Schettini(Target (United States)), Ornella Garrone(Azienda Sanitaria Ospedaliera S.Croce e Carle Cuneo), Massimiliano Alù(University of Palermo), Giorgio Mustacchi(University of Trieste), Monica Giordano(Ospedale Sant'Anna), Antônio Bernardo(Fondazione Salvatore Maugeri), P. Pronzato(Accademia Nazionale dei Lincei), Claudia De Angelis(University of Naples Federico II), Maria Riemma(Istituto Nazionale Tumori IRCCS "Fondazione G. Pascale"), Paolo Marchetti(Istituto Dermopatico dell'Immacolata), Alessandra Fabi(Agostino Gemelli University Polyclinic), Lorenzo Livi(European Society for Sexual Medicine), C. Taverniti(Azienda Ospedaliera Citta' della Salute e della Scienza di Torino), Anna Turletti(Ospedale Martini), Lucia Del Mastro(Ospedale Policlinico San Martino), Sabino De Placido, Ferdinando Riccardi(Ospedale Antonio Cardarelli), Palma Pugliese(Ospedale Sant'Anna)
Cited by 0
Related Papers
FOLFOXIRI plus bevacizumab versus FOLFIRI plus bevacizumab as first-line treatment of patients with metastatic colorectal cancer: updated overall survival and molecular subgroup analyses of the open-label, phase 3 TRIBE study
|The Lancet Oncology|2015|1.1k
Survival and safety of exemestane versus tamoxifen after 2–3 years' tamoxifen treatment (Intergroup Exemestane Study): a randomised controlled trial
|The Lancet|2007|912
Early breast cancer: ESMO Clinical Practice Guideline for diagnosis, treatment and follow-up
|Annals of Oncology|2023|830
Primary results from IMpassion131, a double-blind, placebo-controlled, randomised phase III trial of first-line paclitaxel with or without atezolizumab for unresectable locally advanced/metastatic triple-negative breast cancer
|Annals of Oncology|2021|743
Taxane-Based Combinations As Adjuvant Chemotherapy of Early Breast Cancer: A Meta-Analysis of Randomized Trials
|Journal of Clinical Oncology|2007|413